Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.420
+0.200 (4.74%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 29 employees as of March 31, 2026. The number of employees increased by 6 or 26.09% since the number was last reported on December 31, 2025.
Employees
29
Change
6
Growth
26.09%
Revenue / Employee
n/a
Profits / Employee
-$3,993,310
Market Cap
237.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 29 | 6 | 26.09% |
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Codexis | 146 |
| Coherus Oncology | 145 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Fulcrum Therapeutics | 55 |
| Cybin | 50 |
WHWK News
- 9 days ago - Whitehawk Therapeutics Transcript: AGM 2026 - Transcripts
- 17 days ago - Whitehawk Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 20 days ago - Whitehawk Therapeutics presents real-world analysis on SEZ6 - TheFly
- 21 days ago - Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 - PRNewsWire
- 23 days ago - Whitehawk Therapeutics Registration statement: Registration filing - Filings
- 23 days ago - Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference - PRNewsWire
- 24 days ago - Whitehawk Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 4 weeks ago - Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload - PRNewsWire